|
Match
|
Document |
Document Title |
|
|
7579020 |
Controlled release arginine α-ketoglutarate
An oral formulation of arginine α-ketoglutarate is disclosed which formulation is comprised of arginine α-ketoglutarate and one or more excipient materials. A wide range of different controlled...
|
|
|
7553497 |
Gelatin hard capsule enhancing the film strength
A process for preparing gelatin hard capsule having enhanced film strength by the steps including i) adding 1˜10 wt part of PEG mixture of PEG 600 and PEG 1500 in weight ratio 40˜60:60˜40 to the...
|
|
|
7541422 |
Enzyme-catalyzed process for the preparation of macrocyclic polyester oligomers
A process for the enzyme-catalyzed preparation of cyclic ester oligomers from dicarboxylic acids and/or dicarboxylic acid derivatives and diols, hydroxycarboxylic acids and/or hydroxycarboxylic...
|
|
|
7540600 |
Release agent applicator for imaging members in solid ink jet imaging systems
A release agent applicator applies release agent to an imaging drum and absorbs release agent metered from the drum to extend the operational life of a image drum maintenance unit. The applicator...
|
|
|
7527808 |
Amorphous cefditoren pivoxil composition and process for producing the same
An objective of the present invention is to provide an amorphous cefditoren pivoxil composition possessing excellent stability and dissolvability and to provide a production process of the...
|
|
|
7524515 |
Pharmaceutical safety dosage forms
Pharmaceutical safety dosage forms are provided which include a pharmaceutical and an antagonist to the pharmaceutical. The safety dosage forms are such that the antagonist has no significant...
|
|
|
7514100 |
Controlled release hydrocodone formulations
A solid oral controlled-release dosage form of hydrocodone is disclosed, the dosage form comprising an analgesically effective amount of hydrocodone or a pharmaceutically acceptable salt thereof,...
|
|
|
7498044 |
Dosage form and method for producing the same
The invention relates to a process for producing a coated drug form or a drug form in the form of an active ingredient matrix, by processing a copolymer, an active pharmaceutical ingredient, a core...
|
|
|
7494667 |
Blends of different acyl gellan gums and starch
The present invention relates to a method of producing a film forming blend of different acyl gellan gums with starch having similar textural and functional properties compared to gelatin. Films...
|
|
|
7485609 |
Encapsulated liquid cleanser
A personal cleansing article having a capsule and a liquid cleansing composition contained within the capsule is disclosed. The capsule is made to contain a trigger such that upon the occurrence of...
|
|
|
7476403 |
Oral extended-release composition
The invention is directed to controlled release formulations containing drugs which are preferably considered sparingly soluble to insoluble and which are suitable for administration to a patient...
|
|
|
7470435 |
Extended release venlafaxine formulation
A controlled release dosage form of venlafaxine that comprises an immediate release pellet and an extended release pellet.
|
|
|
7465462 |
Multiparticulate controlled release selective serotonin reuptake inhibitor formulations
A multiparticulate controlled release selective serotonin reuptate inhibitor (SSRI) formulation for oral administration is provided. The formulation includes particles of an SSRI or a...
|
|
|
7462367 |
Anticholinergic powder formulations for inhalation
An inhalable powder comprising:
(a) an active substance consisting essentially of a compound of formula 1
wherein X − is a pharmaceutically acceptable anion; and (b) a...
|
|
|
7459173 |
Medicament for prevention and treatment of bone fracture and osteoporosis
A pharmaceutical composition which can be used to prevent and treat bone fracture and osteoporosis. The composition is composed of Semen lactucae sativae 0.1-1, Lignum aquilariae resinatum ...
|
|
|
7452552 |
***WITHDRAWN PATENT AS PER THE LATEST USPTO WITHDRAWN LIST***
Pharmaceutical compositions for lipophilic drugs
Stable solutions of lipophilic drugs, such as cyclosporin, forming a polar lipid self-emulsifying drug delivery system. The solutions can include lipophilic drugs, such as cyclosporin, dissolved in...
|
|
|
7445796 |
Pharmaceutically active particles of a monomodal particle size distribution and method
A method of obtaining improved reproducibility of dissolution profiles of dosage forms containing pharmaceutically active particles includes steps of screening raw pharmaceutically active particles...
|
|
|
7445795 |
Delivery device, method of using and method of manufacturing
An active principle delivery device ( 1 ) comprising an inner capsule ( 4 ) within an outer capsule ( 2 ), the inner and outer capsules ( 4,2 ) containing the same active principle ( 5,3 ), with at...
|
|
|
7438930 |
Controlled release formulations having rapid onset and rapid decline of effective plasma drug concentrations
The invention is directed to oral modified/controlled release drug formulations which provide a rapid initial onset of effect and a prolonged duration of effect. Preferably, the peak concentration...
|
|
|
7435715 |
Microcapsules
Microcapsules for use in liquid detergents having a core and a polyelectrolyte complex shell in the form of a semipermeable membrane capable of withstanding a force before bursting of from about 20...
|
|
|
7431944 |
Delivery of multiple doses of medications
Dosage forms for oral administration of a methylphenidate drug are provided. The dosage forms provide a substantially immediate dose of methylphenidate upon ingestion, followed by one or more...
|
|
|
7427413 |
Stable shaped particles of crystalline organic compounds
The present invention provides storage stable, shaped particles of allotropic organic compounds. The particles of the present invention can be shaped according to the desired application. Preferred...
|
|
|
7425342 |
Odourless garlic supplement comprising an enteric coating and a deodorising layer
A garlic supplement comprising: (a) one or more cores comprising garlic; (b) an enteric coating encasing the core(s) which is insoluble at pH less than about 5 but soluble at a pH greater than...
|
|
|
7422758 |
Sustained release vitamin composition
A therapeutic formulation in the form of a beadlet, suitable for oral administration and adapted to provide immediate and sustained release of therapeutic material. Each beadlet comprises an...
|
|
|
7419686 |
Opioid agonist/antagonist combinations
The invention is directed in part to oral dosage forms comprising a combination of an orally analgesically effective amount of an opioid agonist and an orally active opioid antagonist, the opioid...
|
|
|
7408018 |
Elastomeric functional biodegradable copolyester amides and copolyester urethanes
The invention provides elastomeric copolyester amides, elastomeric copolyester urethanes, and methods for making the same. The polymers are based on α-amino acids and possess physical, chemical...
|
|
|
7404971 |
Porous gelatin material, gelatin structures, methods for preparation of the same and uses thereof
The present invention relates to a porous gelatin material in the form of spherical particles with a continuous pore structure and cast, three-dimensional, porous gelatin structures. The invention...
|
|
|
7404968 |
Metering and packaging of controlled release medication
Controlled quantities of powdered medication are formed in controlled release packages using electrostating metering. Also provided are combination medication therapy delivery packages comprising...
|
|
|
7399488 |
Abuse-deterrent pharmaceutical compositions of opiods and other drugs
An abuse-deterrent pharmaceutical composition has been developed to reduce the likelihood of improper administration of drugs, especially drugs such as opiods. In the preferred embodiment, a drug...
|
|
|
7396546 |
Anti-microbial compositions and methods of using same
An anti-microbial composition is provided. The anti-microbial composition includes a first ingredient obtainable from ginger, a second ingredient obtainable from green tea, an optional third...
|
|
|
7387806 |
Method of using geranium oil and sophora root extracts as a supporting composition in cancer treatments
A method of administering an herbal composition, comprising geranium oil and extracts from roots of the plants of the genus Sophora to mammalian animals undergoing cancer treatments that induce...
|
|
|
7384653 |
Oral dosage form comprising a therapeutic agent and an adverse-effect agent
The present invention provides an oral dosage form comprising a first composition and a second composition. The first composition comprises an effective amount of a therapeutic agent and the second...
|
|
|
7378102 |
Diclofenac sodium oral pharmaceutical
The present invention relates to a diclofenac sodium oral pharmaceutical containing diclofenac sodium, a nonionic surfactant, a cholic acid derivative as an absorption promoting agent, and a...
|
|
|
7374781 |
Sustained release formulations containing acetaminophen and tramadol
A sustained release formulation as a unit dose contains 100 mg-1000 mg of Acetaminophen and 15 mg-150 mg of tramadol hydrochloride, which comprises of 1) an immediate release portion comprising of...
|
|
|
7374780 |
Two part hard shell capsule made of poly(1,4-α-D-glucan) and starch
The present invention relates to hard shell capsules consisting of two parts made from a poly(1,4-α-D-glucan)and starch based composition and the manufacturing thereof, preferentially by a dipping...
|
|
|
7374779 |
Pharmaceutical formulations and systems for improved absorption and multistage release of active agents
The present invention pertains to pharmaceutical formulations and systems for delivery of active agents, wherein a first fraction of an active agent is suspended in a vehicle and a second fraction...
|
|
|
7368120 |
Methods and compositions for treating pulmonary disorders using optically pure (R,R)-formoterol
A method and composition are disclosed utilizing the pure (R,R) isomer of formoterol, which is a potent bronchodilator with reduced adverse effects, a low incidence of the development of tolerance...
|
|
|
7344738 |
Herbal composition for treatment of immunocompromised conditions
A pharmaceutical or medicinal preparation comprising a combination of two herbal compositions to be administered together. The first herbal composition comprises a mixture of the following herbs: ...
|
|
|
7341742 |
Simethicone containing tablet composition and method
A process and pharmaceutical composition containing simethicone and magnesium carbonate allows a higher production rate of simethicone containing tablets and a more consistent end product tablet....
|
|
|
7338943 |
Hyaluronic acid in soft gel form
An orally administered soft gelatin formulation preparation of low molecular weight Hyaluronic Acid (HA) for use as a nutritional supplement to provide the primary benefit of internally causing the...
|
|
|
7332181 |
Composition for managing diabetes, obesity, and hyperlipidemia and associated methods
A nutritional supplement includes a first formulation including minerals: chromium polynicotinate, magnesium glycinate, manganese sulfate, selenium, vanadyl sulfate, zinc gluconate, copper...
|
|
|
7332177 |
Method and formulation for treating resistance to antihypertensives and related conditions
A method for the prevention or treatment of symptoms of hypertension in a patient who is resistant to antihypertensive effects of an antihypertensive compound administered in the absence of...
|
|
|
RE40059 |
Sensitive substance encapsulation
A process for stabilizing a sensitive substance; (a) plating a sensitive substance onto a solid carrier under a controlled atmosphere to reduce loss of the sensitive substance; (b) encapsulating...
|
|
|
7323452 |
Method for the accelerated in vivo removal of ethanol
A method for accelerating the process of removing ethanol from the blood through the use of certain additives that accelerate the metabolic oxidation of ethanol, and others which in addition act as...
|
|
|
7320802 |
Methods of treatment using nanoparticulate fenofibrate compositions
The present invention is directed to fibrate compositions having improved pharmacokinetic profiles and reduced fed/fasted variability. The fibrate particles of the composition have an effective...
|
|
|
7318934 |
Method for treating wounds to promote healing
A method of treating a mammal to promote wound healing in the mammal in need thereof, comprising orally administering to the mammal an effective amount of a palatable, concentrated protein...
|
|
|
7314640 |
Formulation and process for drug loaded cores
The present invention relates to a controlled release pellet of metoprolol and its pharmaceutically acceptable salts that uses a water soluble or a water swellable inert starting seed or core.
|
|
|
7311925 |
Methods and compositions for blocking microbial adherence to eukaryotic cells
A method of blocking microbial adherence to a eukaryotic cell surface in a mammal by applying a pharmacologically acceptable composition containing at least one compound selected from the group...
|
|
|
7309719 |
Stabilized pharmaceutical preparation of gamma-aminobutyric acid derivatives and process for preparing the same
The present invention provides a stabilized pharmaceutical preparation of a 4-amino-3-substituted-butanoic acid derivative which can be obtained by incorporating an amino acid as a stabilizer.
|
|
|
7309499 |
Fish gelatin hard capsule and its preparation method
The object of the present invention is to provide a process for preparing fish gelatin capsule comprising the steps of; i) preparing a mixed solution of pectin and glycerin; ii) adding said mixed...
|